These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20372120)

  • 1. Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.
    Chang L; Drossman DA
    Am J Gastroenterol; 2010 Apr; 105(4):722-30. PubMed ID: 20372120
    [No Abstract]   [Full Text] [Related]  

  • 2. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Jan; 75(13):3471-2. PubMed ID: 20349552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 8. Good clinical practices.
    McGirl GN
    Qual Assur; 1994 Jun; 3(2):126-30. PubMed ID: 7804627
    [No Abstract]   [Full Text] [Related]  

  • 9. Researchers left to guess at outcomes of most cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
    [No Abstract]   [Full Text] [Related]  

  • 10. The placebo: promise and compromise.
    Regan J; Hamer G; Wright A; Armour A; Fu J
    Tenn Med; 2005 Mar; 98(3):138-9. PubMed ID: 15974105
    [No Abstract]   [Full Text] [Related]  

  • 11. Gender differences in research.
    Rogers B
    AAOHN J; 1994 Jan; 42(1):30-2. PubMed ID: 8147983
    [No Abstract]   [Full Text] [Related]  

  • 12. Major medical journals will require registration of clinical trials for publication.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Oct; 15(19):1-2, 6-7. PubMed ID: 15473047
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
    Stark Y
    Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical research: outlook from industry.
    Echols R
    Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA issues guidance on race and ethnicity data.
    Meadows M
    FDA Consum; 2003; 37(3):36. PubMed ID: 12793392
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials end at gene-therapy institute..
    Smaglik P
    Nature; 2000 Jun; 405(6786):497. PubMed ID: 10850679
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving the status of clinical trials in pediatric gastrointestinal diseases.
    Oliva-Hemker M; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2002 Oct; 35(4):468-9. PubMed ID: 12402967
    [No Abstract]   [Full Text] [Related]  

  • 19. Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
    Weiskopf RB;
    Acad Emerg Med; 2007 Apr; 14(4):e71-3. PubMed ID: 17322571
    [No Abstract]   [Full Text] [Related]  

  • 20. Recruiting human subjects without IRB review/approval.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.